SMPD3 and neoplasm: Several studies have already shown that modulating certain proteins or lipids (e.g., Rab27a, nSMase2, farnesyl transferase, Ras, ceramide) involved in the biogenesis and secretion mechanisms of EVs effectively reduced the level of tumor EVs in the extracellular environment, thereby increasing sensitivity to chemotherapy and reducing tumor progression[6-13].